1-Chloro-1,2-dibromo-1,2,2-trifluoroethane Cas:354-51-8

We are 1-Chloro-1,2-dibromo-1,2,2-trifluoroethane CAS:354-51-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


1-Chloro-1,2-dibromo-1,2,2-trifluoroethane

Synonyms:
1,2-Dibromochlorotrifluoroethane
EINECS 206-562-5
1,2-Dibromo-1-chlorotrifluoromethane
1-chloro-1,2-dibromotrifluoroethane
1-Chloro-1,2-dibromo-1,2,2-trifluoroethane
1,2-Dibromo-1-chloro-1,2,2-trifluoroethane
 
Molecular Formula: C2Br2ClF3
Molecular weight:276.27800
 
Density: 2,248 g/cm3
Boiling point: 93-94°C
Melting point: -72,9°C
Flash point: 9.1ºC
Refractive index: 1.4275

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.



Market News: Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.”N-Cyclopropylmethyl-4-chlorbenzamid manufacturer.The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. Lithium; [((E)-4,4-dimethyl-3-oxo-1-phenyl-pent-1-enyl)-hydrazono]-phenyl-acetate supplier Elliott made its intention for a C-suite overhaul clear in an open letter early July. The activist investor called on GSK to appoint a new board directors with biopharma and consumer health expertise to select the leaders for the two companies. 2,5-Cyclohexadiene-1-carbonitrile, 1-cyclohexyl-3-methyl- producer

Related Products
Product Name
pyrethrum extract Cas:8003-34-7 View Details
3-(Dimethylamino)-1-(2-thienyl)-1-propanol Cas:NO:13636-02-7 View Details
1,3-dichlorobenzene Cas:541-73-1 View Details
N-Benzoylcytidine manufacturer Guanosine5′-(tetrahydrogen Triph) (GTP-Na2) Cas:56001-37-7 manufacturer Ethyl 2-bromo-2-ethylbutanoate Cas:6937-28-6 manufacturer hydrogenated polyisobutylene Cas:68937-10-0 manufacturer Silver nitrite Cas:7783-99-5 manufacturer